My hope is that years from now, when we look back on the coronavirus disease 2019 (COVID-19) pandemic, it will have served a few purposes.
Mike Hennessy Sr
Advertisement
Articles by Mike Hennessy Sr
MJH Associates, Inc & the FDA are both committed to eliminating inefficiencies and hype to deliver the most timely and relevant information to health care providers.
Antibiotic resistance continues to grow, and it’s plaguing health care providers and patients alike.
Advertisement
Latest Updated Articles
- Arming Health Care Providers Against Growing Antimicrobial Resistance
Published: April 27th 2018 | Updated:
- Cutting the Drug Development Red Tape
Published: June 28th 2018 | Updated:
- The Future of Health Care After COVID-19
Published: June 5th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
2
Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies
3
Streamlining IV-to-Oral Transitions in Pneumonia Care: Duration, Tailoring, and Post-Discharge Considerations
4
Maldives Validated by WHO as First Country to Achieve Triple EMTCT of HIV, Syphilis, and Hepatitis B
5
